Royal Bank Of Canada Xeris Biopharma Holdings, Inc. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 14,100 shares of XERS stock, worth $50,619. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,100
Previous 30,260
53.4%
Holding current value
$50,619
Previous $86,000
45.35%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding XERS
# of Institutions
162Shares Held
61.5MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$37.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$28.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$12 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$12 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$10.3 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $488M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...